Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial.

Dickinson L, Gurjar R, Stöhr W, Bonora S, Owen A, D'Avolio A, Cursley A, Molina JM, Fäetkenheuer G, Vandekerckhove L, Di Perri G, Pozniak A, Richert L, Raffi F, Boffito M, NEAT001/ANRS143 Study Group

Open source

DOI: 10.1093/jac/dkz479
Published: 2020 Mar 1
Container: The Journal of antimicrobial chemotherapy
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jac/dkz479,
  title = {Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial.},
  author = {Dickinson L and Gurjar R and Stöhr W and Bonora S and Owen A and D'Avolio A and Cursley A and Molina JM and Fäetkenheuer G and Vandekerckhove L and Di Perri G and Pozniak A and Richert L and Raffi F and Boffito M and NEAT001/ANRS143 Study Group},
  year = {2020},
  journal = {The Journal of antimicrobial chemotherapy},
  doi = {10.1093/jac/dkz479},
  url = {https://doi.org/10.1093/jac/dkz479}
}

RIS

TY  - JOUR
TI  - Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial.
AU  - Dickinson L
AU  - Gurjar R
AU  - Stöhr W
AU  - Bonora S
AU  - Owen A
AU  - D'Avolio A
AU  - Cursley A
AU  - Molina JM
AU  - Fäetkenheuer G
AU  - Vandekerckhove L
AU  - Di Perri G
AU  - Pozniak A
AU  - Richert L
AU  - Raffi F
AU  - Boffito M
AU  - NEAT001/ANRS143 Study Group
PY  - 2020
JO  - The Journal of antimicrobial chemotherapy
DO  - 10.1093/jac/dkz479
UR  - https://doi.org/10.1093/jac/dkz479
ER  -

APA

L, D., R, G., W, S., S, B., A, O., A, D., A, C., JM, M., G, F., L, V., G, D. P., A, P., L, R., F, R., M, B., & Group, N. S. (2020). Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial.. The Journal of antimicrobial chemotherapy. https://doi.org/10.1093/jac/dkz479

Source records

pubmed · retrieved 2026-09-25T01:44:40.716Z